Literature DB >> 16378361

An anthraquinone with potent quinone reductase-inducing activity and other constituents of the fruits of Morinda citrifolia (noni).

Alison D Pawlus1, Bao-Ning Su, William J Keller, A Douglas Kinghorn.   

Abstract

Morinda citrifolia, commonly known as noni, has a long history of utilization throughout much of tropical Polynesia and is considered to be the second most important medicinal plant in the Hawaiian Islands. Recently, the use of noni as a dietary supplement in the United States has greatly increased. Bioassay-guided fractionation of a dichloromethane-soluble partition of a MeOH extract of noni fruits has led to the isolation of an extremely potent quinone reductase inducer, 2-methoxy-1,3,6-trihydroxyanthraquinone (1). This new anthraquinone (1) was nearly 40 times more potent than a positive control, l-sulforaphane. Furthermore, compound 1 demonstrated no discernible cytotoxicity at the highest dose tested. In addition to compound 1, 11 known compounds were also isolated and identified in the present investigation. This is the first report of the isolation of anthraquinones from noni fruits.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16378361     DOI: 10.1021/np050383k

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  14 in total

1.  Multiple berry types prevent N-nitrosomethylbenzylamine-induced esophageal cancer in rats.

Authors:  Gary D Stoner; Li-Shu Wang; Claire Seguin; Claudio Rocha; Kristen Stoner; Steven Chiu; A Douglas Kinghorn
Journal:  Pharm Res       Date:  2010-03-16       Impact factor: 4.200

Review 2.  Natural products as aromatase inhibitors.

Authors:  Marcy J Balunas; Bin Su; Robert W Brueggemeier; A Douglas Kinghorn
Journal:  Anticancer Agents Med Chem       Date:  2008-08       Impact factor: 2.505

Review 3.  Current status and contemporary approaches to the discovery of antitumor agents from higher plants.

Authors:  Garima Agarwal; Peter J Blanco Carcache; Ermias Mekuria Addo; A Douglas Kinghorn
Journal:  Biotechnol Adv       Date:  2019-01-08       Impact factor: 14.227

4.  Noni juice is not hepatotoxic.

Authors:  Brett-J West; C-Jarakae Jensen; Johannes Westendorf
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

5.  Docking simulation and ADMET prediction based investigation on the phytochemical constituents of Noni (Morinda citrifolia) fruit as a potential anticancer drug.

Authors:  Kaliraj Chandran; Drose Ignatious Shane; Azar Zochedh; Asath Bahadur Sultan; Thandavarayan Kathiresan
Journal:  In Silico Pharmacol       Date:  2022-08-25

6.  Ethnoveterinary application of Morinda citrifolia fruit puree on a commercial heifer rearing facility with endemic salmonellosis.

Authors:  V J Brooks; T J De Wolfe; T J Paulus; J Xu; J Cai; N S Keuler; R G Godbee; S F Peek; S M McGuirk; B J Darien
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-10-01

7.  Antioxidant and antimutagenic activities of Randia echinocarpa fruit.

Authors:  María Elena Santos-Cervantes; María Emilia Ibarra-Zazueta; Guadalupe Loarca-Piña; Octavio Paredes-López; Francisco Delgado-Vargas
Journal:  Plant Foods Hum Nutr       Date:  2007-06-19       Impact factor: 4.124

8.  Three bianthraquinone derivatives from the mangrove endophytic fungus Alternaria sp. ZJ9-6B from the South China Sea.

Authors:  Cai-Huan Huang; Jia-Hui Pan; Bin Chen; Miao Yu; Hong-Bo Huang; Xun Zhu; Yong-Jun Lu; Zhi-Gang She; Yong-Cheng Lin
Journal:  Mar Drugs       Date:  2011-05-12       Impact factor: 6.085

9.  Morinda citrifolia (Noni) Juice Augments Mammary Gland Differentiation and Reduces Mammary Tumor Growth in Mice Expressing the Unactivated c-erbB2 Transgene.

Authors:  William P Clafshenkel; Tracy L King; Mary P Kotlarczyk; J Mark Cline; Warren G Foster; Vicki L Davis; Paula A Witt-Enderby
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-26       Impact factor: 2.629

10.  Antidiabetic Effect of Morinda citrifolia (Noni) Fermented by Cheonggukjang in KK-A(y) Diabetic Mice.

Authors:  So-Young Lee; So-Lim Park; Jin-Taek Hwang; Sung-Hun Yi; Young-Do Nam; Seong-Il Lim
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.